140 related articles for article (PubMed ID: 38618505)
1. The physiology and pathophysiology of the factor VIII complex.
Hamer RJ; Houdijk WP; Sixma JJ
Crit Rev Oncol Hematol; 1986; 6(1):19-54. PubMed ID: 3096583
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand disease type 2N: An update.
Seidizadeh O; Peyvandi F; Mannucci PM
J Thromb Haemost; 2021 Apr; 19(4):909-916. PubMed ID: 33497541
[TBL] [Abstract][Full Text] [Related]
3. Factor VIII as a Novel Biomarker for Diagnosis, Prognosis, and Therapy Prediction in Human Cancer and Other Disorders.
Khalilian S; Mohajer Z; Ghafouri-Fard S
Avicenna J Med Biotechnol; 2024; 16(2):68-80. PubMed ID: 38618505
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
[TBL] [Abstract][Full Text] [Related]
5. The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.
Shi Q; Schroeder JA; Kuether EL; Montgomery RR
J Thromb Haemost; 2015 Jul; 13(7):1301-9. PubMed ID: 25955153
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor VIII regulates von Willebrand factor homeostasis invivo.
Cao W; Trask AR; Bignotti AI; George LA; Doshi BS; Sabatino DE; Yada N; Zheng L; Camire RM; Zheng XL
J Thromb Haemost; 2023 Dec; 21(12):3477-3489. PubMed ID: 37726033
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
Favaloro EJ; Mohammed S; Vong R; Pasalic L
Methods Mol Biol; 2023; 2663():679-691. PubMed ID: 37204745
[TBL] [Abstract][Full Text] [Related]
8. The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies.
Comerford C; Glavey S; Quinn J; O'Sullivan JM
J Thromb Haemost; 2022 Aug; 20(8):1766-1777. PubMed ID: 35644028
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII as a potential player in cancer pathophysiology.
Walker GE; Merlin S; Zanolini D; Vandoni A; Volpe A; Gaidano G; Valente G; Olivero M; Follenzi A
J Thromb Haemost; 2022 Mar; 20(3):648-660. PubMed ID: 34847278
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel miRNAs in the F8 Gene Via Bioinformatics Tools.
Rezaei H; Motovali-Bashi M; Khalilian S
Iran J Biotechnol; 2021 Apr; 19(2):e2700. PubMed ID: 34435059
[TBL] [Abstract][Full Text] [Related]
11. Experimental validation of a predicted microRNA within human
Jalali-Qomi S; Motovali-Bashi M; Rezaei H; Khalilian S
Mol Biol Res Commun; 2021 Jun; 10(2):45-53. PubMed ID: 34316492
[TBL] [Abstract][Full Text] [Related]
12. Hsa-miR-5581-3p and Hsa-miR-542-3p Target the
Meng F
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021041. PubMed ID: 34276910
[TBL] [Abstract][Full Text] [Related]
13. Mutation detection and inhibitor risk in Iranian patients with Hemophilia A: Six novel mutations.
Nasirnejad Sola F; Morovvati S; Sabetghadam Moghadam M; Entezari M
Clin Case Rep; 2020 Dec; 8(12):2976-2985. PubMed ID: 33363863
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
